Maynard Um
-
-
-
-
-
-
-
Cue Biopharma (CUE) An Attractive Investment Opportunity - Citizens
-
-
-
-
-
-
-
Cue Biopharma Inc. (CUE) Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Cue Biopharma (CUE)
-
-
-
-
-
-
-
Cue Biopharma (CUE) PT Lowered to $4 at Stifel
-
-
-
-
404,878 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

